Harmony Biosciences develops and sells WAKIX for narcolepsy and other treatments for rare neurological diseases. It last closed at $33.01 on Nov 17, up 0.15% on the day.
Only 1 firm rated HRMY in the past 90 days, not enough for a consensus
Average 12-month target
$60.00
▲ 81.8% upside
Based on 1 analyst who set a price target on HRMY in the past 90 days. The average target is $60.00, with a high of $60.00 and a low of $60.00, compared with the last close of $33.01.
Low $60.00Avg $60.00High $60.00
Blue marker: last close $33.01
Highest target$60.00
Average target$60.00
Lowest target$60.00
Latest rating changes
Wolfe ResearchInitiated
Aug 26Buy$60
Truist SecuritiesMaintained
Aug 5Hold$34
NeedhamMaintained
Aug 4Buy$50
MizuhoMaintained
Jul 31Buy$51
HC Wainwright & Co.Reiterated
Jul 16Buy$55
Date
Firm
Action
Rating
Price target
Aug 26
Wolfe Research
Initiated
Buy
$60
Aug 5
Truist Securities
Maintained
Hold
$34
Aug 4
Needham
Maintained
Buy
$50
Jul 31
Mizuho
Maintained
Buy
$51
Jul 16
HC Wainwright & Co.
Reiterated
Buy
$55
Loading…
Technical Analysis
HRMY · as of the Nov 17 close · updated after every close
Turning down, nearing oversold
The stock is 8% below its 20 day and 16% below its 50 day average. It is 5% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot at $32.94, and the nearest resistance the Pivot R1 at $33.36.
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 4.6%/day
Key levels
$43.4952 week high+31.7%
$38.2850 day average+16.0%
$37.99100 day average+15.1%
$35.5620 day average+7.7%
$34.53200 day average+4.6%
$34.38Swing high (Nov 11)+4.2%
$33.36Pivot R1+1.1%
$33.01Last close
$32.94Pivot−0.2%
$32.59Pivot S1−1.3%
$32.27Swing low (Nov 6)−2.2%
$25.9052 week low−21.5%
Indicators
RSI (14)
33.89
Weak, oversold below 30
Neutral
MACD
-1.48
Below its signal line
Bearish
Stochastic
14.1
Near the bottom of its range
Oversold
ADX (14)
36.1
Trending down
Williams %R
-89.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-85.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−10.8%
Change over 10 sessions
Bearish
ATR (14)
$1.51
Typical daily range, 4.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 9.6%/day
Key levels
$43.4952 week high+31.7%
$38.2850 day average+16.0%
$37.99100 day average+15.1%
$35.5620 day average+7.7%
$34.53200 day average+4.6%
$34.38Swing high (Nov 11)+4.2%
$33.36Pivot R1+1.1%
$33.01Last close
$32.94Pivot−0.2%
$32.59Pivot S1−1.3%
$32.27Swing low (Nov 6)−2.2%
$25.9052 week low−21.5%
Indicators
RSI (14)
42.05
Middle of its range
Neutral
MACD
0.17
Below its signal line
Bearish
Stochastic
9.1
Near the bottom of its range
Oversold
ADX (14)
23.6
Weak trend
Williams %R
-93.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-138.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−20.5%
Change over 10 sessions
Bearish
ATR (14)
$3.18
Typical daily range, 9.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for HRMY
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HRMY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow HRMY usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How HRMY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HRMY is in one of them and how their past HRMY trades turned out.
Harmony Biosciences is a neuroscience company based in Plymouth Meeting, Pennsylvania, that focuses on rare neurological diseases. Its main product, WAKIX, is a prescription tablet taken once a day to treat excessive daytime sleepiness and cataplexy in people with narcolepsy. The company is also developing treatments for other rare conditions, including certain epilepsy syndromes. Healthcare providers prescribe its medicines to patients.